This page lists the SEC filings reported by Novo Holdings A/S.
| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13D | 2015-05-13 | Novo A/S | HTG MOLECULAR DIAGNOSTICS, INC | 1,280,185 | 19.0% | EDGAR |
| SC 13G | 2015-05-13 | Novo A/S | Tobira Therapeutics, Inc. | 2,696,405 | 15.5% | EDGAR |
| SC 13D/A | 2015-04-30 | Novo A/S | Flexion Therapeutics Inc | 2,283,131 | 10.6% | EDGAR |
| SC 13G/A | 2015-04-30 | Novo A/S | Inogen Inc | 3,549,320 | 18.4% | EDGAR |
| SC 13D/A | 2015-03-11 | Novo A/S | Ophthotech Corp. | 4,910,489 | 14.4% | EDGAR |
| SC 13G | 2015-02-02 | Novo A/S | NEVRO CORP | 2,194,841 | 8.8% | EDGAR |
| SC 13G | 2015-02-02 | Novo A/S | Inogen Inc | 3,549,320 | 19.1% | EDGAR |
| SC 13G | 2015-02-02 | Novo A/S | ALDER BIOPHARMACEUTICALS INC | 3,201,183 | 8.7% | EDGAR |
| SC 13D/A | 2014-12-18 | Novo A/S | Flexion Therapeutics Inc | 2,283,131 | 11.0% | EDGAR |
| SC 13D/A | 2014-11-18 | Novo A/S | Ophthotech Corp. | 5,915,489 | 17.6% | EDGAR |
| SC 13G | 2014-10-22 | Novo A/S | Tokai Pharmaceuticals Inc | 1,149,706 | 5.1% | EDGAR |
| SC 13G | 2014-08-28 | Novo A/S | Otonomy, Inc. | 2,175,025 | 10.7% | EDGAR |
| SC 13D | 2014-04-03 | Novo A/S | Akebia Therapeutics, Inc. | 1,516,387 | 7.5% | EDGAR |
| SC 13D | 2014-02-26 | Novo A/S | Flexion Therapeutics Inc | 1,783,131 | 11.4% | EDGAR |
| SC 13D/A | 2014-02-24 | Novo A/S | Ophthotech Corp. | 6,910,489 | 20.7% | EDGAR |
| SC 13D | 2013-10-10 | Novo A/S | Ophthotech Corp. | 6,910,489 | 22.9% | EDGAR |
| SC 13D/A | 2012-12-03 | Novo A/S | BIOMIMETIC THERAPEUTICS, INC. | 4,720,065 | 16.7% | EDGAR |
| SC 13D/A | 2009-12-08 | Novo A/S | BIOMIMETIC THERAPEUTICS, INC. | 3,720,065 | 17.1% | EDGAR |
| SC 13D/A | 2009-07-20 | Novo A/S | BIOMIMETIC THERAPEUTICS, INC. | 3,720,065 | 17.1% | EDGAR |
| SC 13D/A | 2009-06-16 | Novo A/S | BIOMIMETIC THERAPEUTICS, INC. | 3,376,659 | 18.0% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.